BioXcel Therapeutics, Inc. (BTAI) Net income 2017–2025
BioXcel Therapeutics, Inc. (BTAI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$69.9MFY2025 · since FY2017: -$4.5M → -$69.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$69.9M | -17.3% |
| FY2024 | -$59.6M | +66.7% |
| FY2023 | -$179.1M | -8.0% |
| FY2022 | -$165.8M | -55.0% |
| FY2021 | -$106.9M | -30.1% |
| FY2020 | -$82.2M | -149.2% |
| FY2019 | -$33.0M | -71.1% |
| FY2018 | -$19.3M | -324.5% |
| FY2017 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice